News

2019

company

year

domain

François Nader, M.D., Joins Moderna’s Board of Directors

Moderna 12.10.2019

Moderna Named Top Employer by Science for Fifth Consecutive Year

Moderna 10.24.2019

Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)

Moderna 10.22.2019

Moderna to Present Data From Two of Its Prophylactic mRNA Vaccines at IDWeek 2019

Moderna 10.02.2019

Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927)

Moderna 09.30.2019

Moderna Announces mRNA Immunotherapy Research Collaboration with Harvard University

Moderna 09.26.2019

Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)

Moderna 09.12.2019

Moderna Appoints Tracey Franklin as Chief Human Resources Officer

Moderna 09.04.2019

Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893m

Moderna 08.19.2019

Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Meeting

Moderna 06.01.2019

Loading